Long intergenic non-protein coding RNA 2839 (LINC02839)

Long intergenic non-protein coding RNA 2839 (LINC02839) is a human non-protein coding gene that produces a long intergenic non-coding RNA (lincRNA) transcript, defined as an autonomously transcribed RNA longer than 200 nucleotides that does not overlap annotated coding genes[1][3][7]. lincRNAs are a subclass of long non-coding RNAs (lncRNAs) playing roles in regulating gene expression, chromatin structure, and RNA processing, frequently exhibiting tissue- or context-specific expression[3][5][7]. Although some lincRNAs have been linked to human diseases or serve as molecular markers, the biological function and disease associations for LINC02839 remain uncharacterized in current genomic resources[1]. ### Key notes: - There is **no evidence LINC02839 is a therapeutic target** (receptor, enzyme, transporter, or traditional drug target). - **No known interacting drugs, mechanisms of action, biomarkers, or disease-specific safety concerns** are associated with LINC02839 as of current databases and literature. - LINC02839 is best classified as a **regulatory non-coding RNA** rather than as a typical "target" in standard drug discovery nomenclature[3][5][7]. If further characterization or experimental data emerges in the future, these attributes may require updating.

Other names

LINC02839